The 12 closest competitors and alternatives to IX Biopharma among pharmaceuticals companies — ranked by similarity to what IX Biopharma actually does, not by market-cap band.
Subscribe to see IX Biopharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IX Biopharma is a Singapore-based specialty pharmaceutical company developing and commercializing medicines using its WaferiX fast-dissolving sublingual wafer drug-delivery technology. It has focused particularly on pain-management and central-nervous-system products, serving patients and healthcare providers through pharmaceutical products such as Wafermine.
IX Biopharma is a pharmaceuticals company headquartered in Singapore. Xcout tracks 9 named people at IX Biopharma, including Janakan Krishnarajah (Chief Operating Officer & Chief Medical Officer).
3 more named people on record for IX Biopharma, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to IX Biopharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Hyphens Pharma International Limited is a Singapore-headquartered pharmaceutical company that develops, licenses, distributes, and markets pharmaceutical and healthcare products. It serves healthcare professionals, hospitals, pharmacies, and consumers across Singapore and other Southeast Asian markets, with a focus on specialty and branded products.
Similar pharmaceuticals company
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Similar pharmaceuticals company
THX Pharma is a biopharmaceutical company that develops therapeutic solutions for rare neurological diseases such as Batten disease, Niemann-Pick type C, and Gaucher disease. The company utilizes antisense oligonucleotides and scientific research to create targeted drug candidates for patients with limited treatment options.
Similar pharmaceuticals company
Orexo AB is a pharmaceutical company that specializes in developing innovative drug delivery technologies, notably its powder-based AmorphOX platform. The company advances proprietary and partnered pharmaceutical products, including treatments, vaccines, and nasal delivery formulations, serving patients and healthcare partners globally.
Similar pharmaceuticals company
J2 Bio-Pharma, LLC is a specialty pharmaceutical company that reformulates neurology medications to address unmet medical needs. The company partners with pharmacies, patients, and businesses in the healthcare sector to develop and commercialize therapeutic products.
Similar pharmaceuticals company
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
Pharmaceuticals & Biotechnology
Nascent Pharma Holdings, Inc. is a pharmaceutical intellectual property holding company that owns and monetizes patents for high-purity liquid cannabinoid formulations. The company serves the health, wellness, cannabis, and medical industries by licensing its proprietary technology for pain management and neurological disorder treatments.
Similar pharmaceuticals company
Slate Medicines is a privately held biotechnology company advancing next-generation therapeutics for headache treatment, with headquarters located in Raleigh, North Carolina and Boston, Massachusetts.
Pharmaceuticals, Biotechnology & Life Sciences
Invex Therapeutics Ltd is an Australian biopharmaceutical company dedicated to researching and developing innovative treatments for various neurological disorders. Their primary focus is Exenatide, a promising therapeutic agent aimed at neurological conditions linked to or resulting from elevated intracranial pressure, including idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. Exenatide has successfully advanced through Phase II clinical trials. The company was founded in 2019 and operates from Perth, Australia.
Similar pharmaceuticals company
Mirata Pharmaceuticals, LLC develops non-addictive pain-relieving drugs as alternatives to prescription opioids. The company serves patients and physicians by creating medications that offer the analgesic benefits of opioids without their severe side effects and addictive properties.
Similar pharmaceuticals company
InstaPill Private Limited is a pharmaceutical contract development and manufacturing organization (CDMO) specializing in advanced lyophilized orally disintegrating tablets (ODTs).
Similar pharmaceuticals company
Smartech Topical, Inc. is a specialty pharmaceutical company that develops patented delivery technology for topical pharmaceutical healthcare solutions. The company focuses on advancing pharmaceutical deliverables across key healthcare categories to improve consumer health and wellbeing.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for IX Biopharmaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →